These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6583982)

  • 1. Spinal 5-HT or NA uptake inhibition potentiates supraspinal morphine antinociception in rats.
    Larsen JJ; Arnt J
    Acta Pharmacol Toxicol (Copenh); 1984 Jan; 54(1):72-5. PubMed ID: 6583982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desipramine potentiates spinal antinociception by 5-hydroxytryptamine, morphine and adenosine.
    Sawynok J; Reid A
    Pain; 1992 Jul; 50(1):113-118. PubMed ID: 1513600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT-uptake inhibition potentiates antinociception induced by morphine, pethidine, methadone and ketobemidone in rats.
    Larsen JJ; Hyttel J
    Acta Pharmacol Toxicol (Copenh); 1985 Sep; 57(3):214-8. PubMed ID: 2865865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebroventricular morphine produces antinociception by evoking gamma-aminobutyric acid release through activation of 5-hydroxytryptamine 3 receptors in the spinal cord.
    Kawamata T; Omote K; Toriyabe M; Kawamata M; Namiki A
    Anesthesiology; 2002 May; 96(5):1175-82. PubMed ID: 11981159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subarachnoidal administration of the 5-HT uptake inhibitor citalopram points to the spinal role of 5-HT in morphine antinociception.
    Larsen JJ; Christensen AV
    Pain; 1982; 14(4):339-345. PubMed ID: 6962420
    [No Abstract]   [Full Text] [Related]  

  • 6. Efflux of 5-hydroxytryptamine and noradrenaline into spinal cord superfusates during stimulation of the rat medulla.
    Hammond DL; Tyce GM; Yaksh TL
    J Physiol; 1985 Feb; 359():151-62. PubMed ID: 2582112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ro 11-2465 (cyan-imipramine), citalopram and their N-desmethyl metabolites: effects on the uptake of 5-hydroxytryptamine and noradrenaline in vivo and related pharmacological activities.
    Pawlowski L; Nowak G; Górka Z; Mazela H
    Psychopharmacology (Berl); 1985; 86(1-2):156-63. PubMed ID: 3927352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lesions to ascending noradrenergic and serotonergic pathways modify antinociception produced by intracerebroventricular administration of morphine.
    Sawynok J; Reid A
    Neuropharmacology; 1989 Feb; 28(2):141-7. PubMed ID: 2497401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citalopram: a new potent inhibitor of serotonin (5-HT) uptake with central 5-HT-mimetic properties.
    Pawłowski L; Ruczyńska J; Górka Z
    Psychopharmacology (Berl); 1981; 74(2):161-5. PubMed ID: 6267647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of morphine antinociception by monoamine reuptake inhibitors in the rat spinal cord.
    Taiwo YO; Fabian A; Pazoles CJ; Fields HL
    Pain; 1985 Apr; 21(4):329-337. PubMed ID: 4000684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal administration of thiorphan, bestatin, desipramine and fluoxetine differentially potentiate the antinociceptive effects induced by beta-endorphin and morphine, administered intracerebroventricularly.
    Suh HH; Tseng LL
    Neuropharmacology; 1990 Mar; 29(3):207-14. PubMed ID: 2139187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of morphine-induced analgesia after repeated injections of methylenedioxymethamphetamine.
    Nencini P; Woolverton WL; Seiden LS
    Brain Res; 1988 Aug; 457(1):136-42. PubMed ID: 2901895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of 5-hydroxytryptamine-containing neurons in antinociception produced by injection of morphine into nucleus raphe magnus or onto spinal cord.
    Vasko MR; Pang IH; Vogt M
    Brain Res; 1984 Jul; 306(1-2):341-8. PubMed ID: 6547871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Test-specific effects of the 5-HT reuptake inhibitors alaproclate and zimelidine on pain sensitivity and morphine analgesia.
    Ogren SO; Holm AC
    J Neural Transm; 1980; 47(4):253-71. PubMed ID: 6446594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the role of 5-hydroxytryptamine in drug-induced antinociception.
    Sugrue MF
    Br J Pharmacol; 1979 Apr; 65(4):677-81. PubMed ID: 435690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intraventricular injection of morphine and beta-endorphin on serotonin release from the spinal cord in rats.
    Jung JS; Song DK; Suh HW; Kim YH
    Pharmacol Biochem Behav; 1994 Dec; 49(4):1037-42. PubMed ID: 7533910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dextromethorphan potentiates morphine-induced antinociception at both spinal and supraspinal sites but is not related to the descending serotoninergic or adrenergic pathways.
    Chow LH; Huang EY; Ho ST; Tsai SK; Tao PL
    J Biomed Sci; 2004; 11(6):717-25. PubMed ID: 15591767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracerebroventricular morphine releases adenosine and adenosine 3',5'-cyclic monophosphate from the spinal cord via a serotonergic mechanism.
    Sweeney MI; White TD; Sawynok J
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1013-8. PubMed ID: 1662270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supraspinal and spinal mechanisms in morphine-induced inhibition of reflex urinary bladder contractions in the rat.
    Dray A; Nunan L
    Neuroscience; 1987 Jul; 22(1):281-7. PubMed ID: 2819776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reduction of antinociceptive effect of morphine administered intraventricularly is correlated with the decrease of serotonin release from the spinal cord in streptozotocin-induced diabetic rats.
    Suh HW; Song DK; Wie MB; Jung JS; Hong HE; Choi SR; Kim YH
    Gen Pharmacol; 1996 Apr; 27(3):445-50. PubMed ID: 8723523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.